[VRTX] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
31-Oct-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 35.16%
YoY- 56.03%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 544,135 714,718 458,706 413,783 431,608 398,080 417,935 19.25%
PBT 35,506 253,533 20,306 -42,034 -18,021 -30,617 -77,829 -
Tax 4,337 3,985 -7,453 503 18,130 5,485 -1,379 -
NP 17,996 247,756 32,945 -41,841 -64,525 -41,631 -75,512 -
Tax Rate -12.21% -1.57% 36.70% - - - - -
Total Cost 526,139 466,962 425,761 455,624 496,133 439,711 493,447 4.37%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 3.31 34.66 7.18 -10.11 -14.95 -10.46 -18.07 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS 0.07 1.01 0.13 -0.17 -0.26 -0.17 -0.31 -
EPS Diluted 0.07 0.99 0.13 -0.17 -0.26 -0.17 -0.31 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.